Trial Profile
A retrospective study evaluating clinical course of biliary tract cancer and its prognostic factors with the standard gemcitabine plus cisplatin treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Adenocarcinoma; Biliary cancer; Carcinoma; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 01 Aug 2017 New trial record
- 01 Jul 2017 Results published in the Cancer Chemotherapy and Pharmacology